Haemonetics Corp (NYSE:HAE)
| CAPS Rating |
|
|---|---|
| Open | $65.77 |
| Previous Close | $66.30 |
| Daily Range | $65.44 - $66.49 |
| 52-Week Range | $54.99 - $70.40 |
| Market Cap | $1.71B |
| P/E Ratio | 19.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 79,501 |
| Average Daily Volume | 0 |
HAE
VS S&P 500 (SPY)
How do you think HAE will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
HAE Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
HAE News and Commentary
- Update on VPHM's Industrial Facility - Analyst Blog – NASDAQ
- Hepatitis C and Orphan Diseases Driving Big Biotech Potential: Geoff Meacham – NASDAQ
- Hepatitis C and Orphan Diseases Driving Big Biotech Potential: Geoff Meacham – NASDAQ
- Haemonetics Beats Estimates - Analyst Blog – NASDAQ
- Haemonetics Beats Analyst Estimates on EPS – The Motley Fool
- Opening View: Futures are Down Amid Ongoing Greece Stability Concerns – NASDAQ
- Priority Review for VPHM's Drug - Analyst Blog – NASDAQ
- Haemonetics Stays Neutral - Analyst Blog – NASDAQ
- ViroPharma's Seizure Drug Reaches UK - Analyst Blog – NASDAQ
- Zacks Sell List Highlights: Foster Wheeler AG, ITT, Spectrum Brands Holdings and Haemonetics - Press – NASDAQ
- ITT CORP (ITT) - Profit Tracks – NASDAQ
- ViroPharma-Halozyme Drug Advances - Analyst Blog – NASDAQ
- Haemonetics Earnings Preview – The Motley Fool
- Haemonetics Shares Plunged: What You Need to Know – The Motley Fool
- Haemonetics May Be Warning You. Are You Listening? – The Motley Fool
- The Best and Worst Medical Device Stocks – SeekingAlpha
- 10 Buys With Historically Low Price to Book Ratios – SeekingAlpha
- Healthcare Sector: Stronger Than It Looks – SeekingAlpha
- Is Haemonetics' Cash Machine Empty? – The Motley Fool
- Haemonetics Passes This Key Test – The Motley Fool
RSS Headlines
Fool UK
